Abstract:PurposeThe purpose of this paper is to provide a physical description of the amorphous state for pharmaceutical materials and to investigate the pharmaceutical implications. Techniques to elucidate structural differences in pharmaceutical solids exhibiting characteristic X-ray amorphous powder patterns are also presented.Materials and MethodsThe X-ray amorphous powder diffraction patterns of microcrystalline cellulose, indomethacin, and piroxicam were measured with laboratory XRPD instrumentation. Analysis of the data were carried out using a combination of direct methods, such as pair distribution functions (PDF), and indirect material modeling techniques including Rietveld, total scattering, and amorphous packing.ResultsThe observation of X-ray amorphous powder patterns may indicate the presence of amorphous, glassy or disordered nanocrystalline material in the sample. Rietveld modeling of microcrystalline cellulose (Avicel® PH102) indicates that it is predominantly disordered crystalline cellulose Form Iβ with some amorphous contribution. The average crystallite size of the disordered nanocrystalline cellulose was determined to be 10.9 nm. Total scattering modeling of ground samples of α, γ, and δ crystal forms of indomethacin in combination with analysis of the PDFs provided a quantitative picture of the local structure during various stages of grinding. For all three polymorphs, with increased grinding time, a two-phase system, consisting of amorphous and crystalline material, continually transformed to a completely random close packed (RCP) amorphous structure. The same pattern of transformation was detected for the Form I polymorph of piroxicam. However, grinding of Form II of piroxicam initially produced a disordered phase that maintained the local packing of Form II but over a very short nanometer length scale. The initial disordered phase is consistent with continuous random network (CRN) glass material. This initial disordered phase was maintained to a critical point when a transition to a completely amorphous RCP structure occurred.ConclusionsTreating X-ray amorphous powder patterns with different solid-state models, ranging from disordered nanocrystalline to glassy and amorphous, resulted in the assignment of structures in each of the systems examined. The pharmaceutical implications with respect to the stability of the solid are discussed.

Structural Interpretation in Composite Systems Using Powder X-ray Diffraction: Applications of Error Propagation to the Pair Distribution Function

Structural characterisation of amorphous solid dispersions via metropolis matrix factorisation of pair distribution function data

Prediction of the physical stability of amorphous solid dispersions: relationship of aging and phase separation with the thermodynamic and kinetic models along with characterization techniques

Towards a robust ad-hoc data correction approach that yields reliable atomic pair distribution functions from powder diffraction data

Modeling the Structure of Ketoprofen-Poly(vinylpyrrolidone) Amorphous Solid Dispersions with Empirical Potential Structure Refinements of X-ray Scattering Data

Using X-ray Diffraction Techniques for Biomimetic Drug Development, Formulation, and Polymorphic Characterization

Solving Complex Structures by Combining Precession Electron Diffraction and X-ray Powder Diffraction Techniques

Using Singular Value Decomposition to Analyze Drug /β-Cyclodextrin Mixtures: Insights from X-ray Powder Diffraction Patterns

Simultaneous XRD-DSC identifies correct drug-polymer solubility and miscibility for enantiotropic solid forms

Structural Characterization of Pharmaceutical Cocrystals with the Use of Laboratory X-ray Powder Diffraction Patterns

Bridging Structural Inhomogeneity to Functionality: Pair Distribution Function Methods for Functional Materials Development

Combining Precession Electron Diffraction Data with X-ray Powder Diffraction Data to Facilitate Structure Solution

Structure determination of organic compounds by a fit to the pair distribution function from scratch without prior indexing

Analysis of Amorphous and Nanocrystalline Solids from Their X-Ray Diffraction Patterns

Prediction of the thermal phase diagram of amorphous solid dispersions by Flory-Huggins theory.

Structural analysis of pharmaceutical tablets using two-dimensional X-ray absorption fine-structure spectroscopy and its combination with X-ray computed tomography

Detour into Two Dimensions: A New Method for Powder Structure Solution

Quantification of Pharmaceutical Compounds Based on Powder X-Ray Diffraction with Chemometrics

Modelling phase separation in amorphous solid dispersions

Structure Determination of Modulated Structures by Powder X-ray Diffraction and Electron Diffraction

Analysis of occupational and displacive disorder using the atomic pair distribution function: a systematic investigation